• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病发展过程中支气管肺泡灌洗液中真菌和细菌的多样性

Diversity of Fungi and Bacteria in Bronchoalveolar Lavage Fluid during Development of Chronic Obstructive Pulmonary Disease.

作者信息

Wu Xin, Wei Xuan, Li Xiaofeng, Deng Jiehua, Zhang Jianquan

机构信息

Department of Respiratory and Critical Medicine, The First Affiliated Hospital of Guangxi Medical University, China.

Department of Respiratory Medicine, The Forth Affiliated Hospital of Guangxi Medical University, China.

出版信息

Jpn J Infect Dis. 2022 Nov 22;75(6):560-568. doi: 10.7883/yoken.JJID.2022.153. Epub 2022 Jul 29.

DOI:10.7883/yoken.JJID.2022.153
PMID:35908874
Abstract

Dynamic changes in the microbiome during chronic obstructive pulmonary disease (COPD) exacerbations remain unclear. Using 16S ribosomal DNA and fungal internal transcribed spacer DNA sequencing, we described the composition and changes in the bacterial and fungal microbiota of bronchoalveolar lavage fluid samples from 15 COPD patients and seven non-COPD patients. In patients with COPD, the dominant bacterial phyla were Proteobacteria, Firmicutes, Bacteroidetes, and Actinobacteria. The most abundant fungal phyla were the Ascomycota and Basidiomycota. In terms of the genera of bacteria and fungi, the numbers of Veillonella, Prevotella-7, Haemophilus, and Aspergillus were significantly higher in patients with COPD than in the non-COPD patients. In addition, after the progression of COPD, the relative abundances of the fungal genera Aspergillus, Mortierella, Grifola, Thermoascus, Russula, and Thermomyces and the bacterial genus Proteobacteria increased significantly. Existing analyses have demonstrated changes in the diversity of bacterial and fungal communities, which appear to be related to COPD. Our results demonstrate the potential utility of microbiota as a possible biomarker for disease progression and provide therapeutic targets for COPD.

摘要

慢性阻塞性肺疾病(COPD)急性加重期微生物群的动态变化仍不清楚。我们使用16S核糖体DNA和真菌内转录间隔区DNA测序,描述了15例COPD患者和7例非COPD患者支气管肺泡灌洗液样本中细菌和真菌微生物群的组成及变化。在COPD患者中,主要的细菌门类为变形菌门、厚壁菌门、拟杆菌门和放线菌门。最丰富的真菌门类是子囊菌门和担子菌门。在细菌和真菌属方面,COPD患者中韦荣球菌属、普雷沃菌属7、嗜血杆菌属和曲霉属的数量显著高于非COPD患者。此外,COPD进展后,真菌属曲霉属、被孢霉属、猪苓属、嗜热子囊菌属、红菇属和嗜热真菌属以及细菌属变形菌门的相对丰度显著增加。现有分析表明细菌和真菌群落的多样性发生了变化,这似乎与COPD有关。我们的结果证明了微生物群作为疾病进展可能的生物标志物的潜在用途,并为COPD提供了治疗靶点。

相似文献

1
Diversity of Fungi and Bacteria in Bronchoalveolar Lavage Fluid during Development of Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病发展过程中支气管肺泡灌洗液中真菌和细菌的多样性
Jpn J Infect Dis. 2022 Nov 22;75(6):560-568. doi: 10.7883/yoken.JJID.2022.153. Epub 2022 Jul 29.
2
The lower airways microbiome and antimicrobial peptides in idiopathic pulmonary fibrosis differ from chronic obstructive pulmonary disease.特发性肺纤维化的下呼吸道微生物组和抗菌肽与慢性阻塞性肺疾病不同。
PLoS One. 2022 Jan 6;17(1):e0262082. doi: 10.1371/journal.pone.0262082. eCollection 2022.
3
The lung microbiome in moderate and severe chronic obstructive pulmonary disease.中重度慢性阻塞性肺疾病的肺部微生物组。
PLoS One. 2012;7(10):e47305. doi: 10.1371/journal.pone.0047305. Epub 2012 Oct 11.
4
Saliva as a non-invasive specimen for COPD assessment.唾液作为 COPD 评估的非侵入性标本。
Respir Res. 2022 Jan 29;23(1):16. doi: 10.1186/s12931-022-01935-9.
5
Variations in fecal microbial profiles of acute exacerbations and stable chronic obstructive pulmonary disease.急性加重期和稳定期慢性阻塞性肺疾病粪便微生物特征的变化。
Life Sci. 2021 Jan 15;265:118738. doi: 10.1016/j.lfs.2020.118738. Epub 2020 Nov 10.
6
Longitudinal analysis of the lung microbiota of cynomolgous macaques during long-term SHIV infection.恒河猴肺部微生物组在长期感染 SHIV 过程中的纵向分析。
Microbiome. 2016 Jul 8;4(1):38. doi: 10.1186/s40168-016-0183-0.
7
The altered sputum microbiome profile in patients with moderate and severe COPD exacerbations, compared to the healthy group in the Indian population.与健康人群相比,印度人群中中度和重度 COPD 加重患者的痰液微生物组谱发生了改变。
F1000Res. 2023 Oct 27;12:528. doi: 10.12688/f1000research.132220.3. eCollection 2023.
8
Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state.慢性阻塞性肺疾病患者临床稳定期痰液微生物组与加重表型的相关性研究。
J Transl Med. 2021 Mar 23;19(1):121. doi: 10.1186/s12967-021-02788-4.
9
Analysis of the lung microbiome in the "healthy" smoker and in COPD.分析“健康”吸烟者和 COPD 患者的肺部微生物组。
PLoS One. 2011 Feb 22;6(2):e16384. doi: 10.1371/journal.pone.0016384.
10
A metagenomic next-generation sequencing (mNGS)-based analysis of bronchoalveolar lavage samples in patients with an acute exacerbation of chronic obstructive pulmonary disease.基于宏基因组下一代测序(mNGS)的慢性阻塞性肺疾病急性加重患者支气管肺泡灌洗液样本分析。
J Mol Histol. 2024 Oct;55(5):709-719. doi: 10.1007/s10735-024-10225-1. Epub 2024 Jul 26.

引用本文的文献

1
Internal transcribed spacer sequencing to explore the intrinsic composition of fungal communities in fungal esophagitis.采用内转录间隔区测序法探究真菌性食管炎中真菌群落的内在组成。
World J Gastroenterol. 2025 Feb 21;31(7):101104. doi: 10.3748/wjg.v31.i7.101104.
2
Periodontopathogens and and Their Roles in the Progression of Respiratory Diseases.牙周病原体及其在呼吸系统疾病进展中的作用。 需注意,原文中“and”重复使用,可能存在错误表述。
Pathogens. 2023 Aug 30;12(9):1110. doi: 10.3390/pathogens12091110.
3
Alteration of Colonic Bacterial and Fungal Composition and Their Inter- and Intra-Kingdom Interaction in Patients with Adenomas with Low-Grade Dysplasia.
低级别异型增生腺瘤患者结肠细菌和真菌组成的改变及其界间和界内相互作用
Microorganisms. 2023 May 18;11(5):1327. doi: 10.3390/microorganisms11051327.